Navigation Links
PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
Date:9/26/2008

t only our third generation rPA vaccine candidate, but also our novel second generation rPA anthrax vaccine, SparVax(TM) which is positioned for near-term procurement consideration. As previously disclosed on July 31, 2008, we submitted our response to a request for proposals to the Department of Health and Human Services (DHHS) for SparVax(TM). The solicitation outlined a requirement to procure 25 million doses of a second generation rPA anthrax vaccine intended for inclusion in the Strategic National Stockpile. We were notified by DHHS recently that our proposal was technically acceptable and within the competitive range. The second generation rPA vaccine market represents another significant opportunity for PharmAthene, with a total potential contract award of between $350 million and $600 million. We are confident in the Company's competitive prospects for this award, which DHHS has stated should be announced by year-end 2008."

About Anthrax

Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis and has the potential to be used as a weapon of bioterror when delivered in an aerosolized form. Following germination of the spores, the bacteria replicates and produces three toxins. Anthrax Protective Antigen (PA) initiates the onset of the illness by attaching to cells in the infected person where it then facilitates entry of the two additional destructive toxins -- Lethal Factor and Edema Factor, into the cell.

Antibiotics are the first line of defense against anthrax infection. However, early identification and treatment are critical for successful outcome. Even with aggressive antibiotic therapy, five of the eleven victims of the 2001 anthrax postal attacks died, underscoring the need for improved vaccines and anti-toxins for the civilian population.

About SparVax(TM) and the Third Generation Anthrax Vaccine

SparVax(TM) is a novel second generation recombinant protective (rPA) anthrax vacc
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008
2. PharmAthene to Present at the UBS Global Life Sciences Conference on Thursday September 25, 2008
3. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
4. PharmAthene Reports Second Quarter 2008 Financial and Operational Results
5. Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene
6. PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel
7. PharmAthene Reports First Quarter 2008 Financial Results
8. PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008
9. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
10. PharmAthene Reports Year-End 2007 Financial Results
11. Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthenes Protexia(R) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Vital Imaging ™ has ... California, San Diego for a joint study which aims ... (Magnetic Resonance Imaging) with that of a supine Dynawell ... pursuit of improved healthcare by combining cutting edge technology ... extremely valuable tool for evaluating pathological changes in the ...
(Date:5/21/2013)... Lake, MN (PRWEB) May 21, 2013 The ... trade show display solution for sales and marketing teams looking ... Displays describes the kit as “everything you’ll need to ... Fusion Fabric Display Kit comes with a number of displays ... all-around trade booth 20 feet by 20 feet in size. ...
(Date:5/20/2013)... Mechanicsburg, Pa (PRWEB) May 20, 2013 ... controller with ramp/soak capabilities. The 5R6-900 benchtop controller ... enclosure, the device can be plugged into the wall ... own power supply. This distinctive detail makes the device ... , The laboratory temperature controller can also be ...
(Date:5/20/2013)... 20, 2013  Dr. Gerald Zon ... research, recently launched a new blog in conjunction with ... zon.trilinkbiotech.com ), focuses on what,s trending in the field ... thought leaders, discussions of research presented at conferences and ... Dr. Zon (PhD Princeton University 1971) developed automated ...
Breaking Biology Technology:Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2New Laboratory Temperature Controller by Oven Industries 2Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2
... yeast ( Saccharomyces cerevisiae ) has been developed which ... waste and hardwoods. Researchers writing in BioMed Central,s open ... creation of the new S. cerevisiae strain, ... final biomass concentration on sugar media composed of two ...
... a single-atomic-layered material made by reacting graphite powders with ... from scientists because of its ability to easily convert ... believe could be used to produce low-cost carbon-based transparent ... professor of materials science and engineering, and his research ...
... June 14 HCL Infosystems, ... a renowned healthcare interoperability and point-of-care solutions provider, ... create India ,s National Health Information Exchange ... portal, electronic health record (EHR), and personal health ...
Cached Biology Technology:Researchers discover new properties of World's thinnest material 2HCL Infosystems Joins Hands With Wellogic to Roll Out Nationwide Health Information Exchange Environment Across India 2HCL Infosystems Joins Hands With Wellogic to Roll Out Nationwide Health Information Exchange Environment Across India 3HCL Infosystems Joins Hands With Wellogic to Roll Out Nationwide Health Information Exchange Environment Across India 4
(Date:5/21/2013)... largest scientific society, invites news media coverage of ... 2013, in Indianapolis, Ind. It will take place ... hotels. , With more than 7,100 presentations on ... astronomy to zoology ― the meeting will offer ... of spot news and feature possibilities. The topics ...
(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center ... 2013 , Why? An annual ... policy developments, manufacturing and installation, drawing on leading experiences ... 2013 edition from a record of more than 900 ... 240 plenary and oral presentations, more than 460 visual ...
(Date:5/21/2013)... 2013 Royal Philips Electronics (NYSE: PHG, AEX: ... portable ultrasound with Philips, industry leading Live 3D TEE, ... xMATRIX with available Live 3D TEE and ICE will ... the EuroPCR, official meeting for the European Association of ... its launch in 2012, Philips CX50 xMATRIX has been ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
... at the University of Minnesota have identified a ... disease begins as a respiratory tract infection, which ... then moves to the lungs, making superantigens (bacterial ... often leading to death due to hypertension and ...
... HIV genome pales in comparison to the 3.2 gigabases ... retrovirus encodes just 14 proteins, which play different roles ... HIV uses the host’s cellular machinery—including RNA polymerases, which ... and infiltrate human chromosomal DNA. Once the virus is ...
... the hoped-for knockout punch breakthrough against the defences of ... resistance. , Techniques such as genomic sequencing and high ... new antibiotic compounds easier and more productive. But in ... hand ?and if three billion years of bacterial history ...
Cached Biology News:U of M researcher examines newly emerging deadly disease 2Novel Enzyme Shows Potential As An Anti-HIV Target 2Novel Enzyme Shows Potential As An Anti-HIV Target 3Learning to fight an adversary that won't stay down 2
Request Info...
Mouse monoclonal [DJR3] to DcR1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Request Info...
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
Biology Products: